Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.94 Delayed Data As of Feb 07 |  +0.04 / +1.38%Today’s Change | 1.85 Today|||52-Week Range 3.64 | +26.18% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 2.90 |
| Today’s open | 2.89 |
| Day’s range | 2.89 - 2.97 |
| Volume | 23,232 |
| Average volume (3 months) | 918,786 |
| Market cap | $455.3M |
Data as of 3:59pm ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | +16.84% |
| Earnings growth (this year) | +45.54% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +58.92% |
| P/E ratio | NM |
| Price/Sales | 37.61 |
| Price/Book | 2.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LXRXLexicon Pharmaceutic... | +0.08 | +3.35% |
| ---- | ||
| INOInovio Pharmaceutica... | +0.03 | +1.63% |
| AVDLAvadel Pharmaceutica... | +0.25 | +3.35% |
Data as of 4:00pm ET, 02/07/2023
Financials
| Next reporting date | March 2, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $11.0M |
| Annual profit (last year) | -$76.2M |
| Net profit margin | -693.91% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
